Dong‐Hao Wu
- Oncology top 10%
- Epidemiology
- Hepatology top 5%
- Cancer Research top 10%
- Molecular Biology
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (12 papers)Inflammatory Biomarkers in Disease Prognosis (9 papers)Cancer, Lipids, and Metabolism (8 papers)
- Cited by
- HepatologyCancer ResearchOncology
- Journals
- Journal of Clinical OncologyBiochemical and Biophysical Research CommunicationsInternational Journal of Biological Macromolecules
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Dong‐Hao Wu
30 papers receiving 542 citations
Peers
Comparison fields: 5 of 69
- Oncology 259
- Epidemiology 192
- Hepatology 172
- Cancer Research 165
- Molecular Biology 116
Countries citing papers authored by Dong‐Hao Wu
This map shows the geographic impact of Dong‐Hao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Hao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Hao Wu more than expected).
Fields of papers citing papers by Dong‐Hao Wu
This network shows the impact of papers produced by Dong‐Hao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Hao Wu. The network helps show where Dong‐Hao Wu may publish in the future.
Co-authorship network of co-authors of Dong‐Hao Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Hao Wu. A scholar is included among the top collaborators of Dong‐Hao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Hao Wu. Dong‐Hao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 10 | |
| 4 | 6 | |
| 5 | 42 | |
| 6 | 29 | |
| 7 | 21 | |
| 8 | 11 | |
| 9 | 32 | |
| 10 | 35 | |
| 11 | 24 | |
| 12 | 10 | |
| 13 | 5 | |
| 14 | 5 | |
| 15 | 25 | |
| 16 | 35 | |
| 17 | 77 | |
| 18 | 11 | |
| 19 | 91 | |
| 20 | 14 |
About Dong‐Hao Wu
Dong‐Hao Wu is a scholar working on Hepatology, Cancer Research and Oncology, having authored 35 papers that have together received 548 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Inflammatory Biomarkers in Disease Prognosis (9 papers) and Cancer, Lipids, and Metabolism (8 papers). The work is most often cited by research in Hepatology (172 citations), Cancer Research (165 citations) and Oncology (259 citations). Dong‐Hao Wu has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Xiaokun Ma, Qu Lin, Zhan‐Hong Chen, Dan‐Yun Ruan, Jing‐Yun Wen, Xing Li, Min Dong, Xiangyuan Wu, Yan‐Fang Xing and Tiantian Wang. Their work appears in journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.